Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

731 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Localized upper extremity edema secondary to Bruton's tyrosine kinase inhibition.
Leung BW, Fay CJ, Said JT, Sheets AR, Lian CG, Brown JR, Castillo JJ, Sarosiek S, Flynn C, LeBoeuf NR. Leung BW, et al. Among authors: flynn c. Leuk Lymphoma. 2023 Dec;64(12):2047-2050. doi: 10.1080/10428194.2023.2245091. Epub 2023 Sep 6. Leuk Lymphoma. 2023. PMID: 37671695 No abstract available.
Deepening of response after completing rituximab-containing therapy in patients with Waldenstrom macroglobulinemia.
Castillo JJ, Gustine JN, Keezer A, Meid K, Flynn CA, Dubeau TE, Chan G, Chen J, Demos MG, Guerrera ML, Jimenez C, Kofides A, Liu X, Munshi M, Tsakmaklis N, Patterson CJ, Xu L, Yang G, Hunter ZR, Treon SP. Castillo JJ, et al. Among authors: flynn ca. Am J Hematol. 2020 Apr;95(4):372-378. doi: 10.1002/ajh.25712. Epub 2020 Jan 7. Am J Hematol. 2020. PMID: 31868242 Free article.
CXCR4 mutational status does not impact outcomes in patients with Waldenström macroglobulinemia treated with proteasome inhibitors.
Castillo JJ, Gustine JN, Meid K, Flynn CA, Demos MG, Guerrera ML, Jimenez C, Kofides A, Liu X, Munshi M, Tsakmaklis N, Patterson CJ, Xu L, Yang G, Hunter ZR, Treon SP. Castillo JJ, et al. Among authors: flynn ca. Am J Hematol. 2020 Apr;95(4):E95-E98. doi: 10.1002/ajh.25730. Epub 2020 Jan 23. Am J Hematol. 2020. PMID: 31943341 Free article. No abstract available.
A matched case-control study comparing features, treatment and outcomes between patients with non-IgM lymphoplasmacytic lymphoma and Waldenström macroglobulinemia.
Castillo JJ, Itchaki G, Gustine JN, Meid K, Flynn CA, Demos MG, Guerrera ML, Jimenez C, Kofides A, Liu X, Munshi M, Tsakmaklis N, Patterson CJ, Xu L, Yang G, Hunter ZR, Treon SP. Castillo JJ, et al. Among authors: flynn ca. Leuk Lymphoma. 2020 Jun;61(6):1388-1394. doi: 10.1080/10428194.2020.1719100. Epub 2020 Jan 29. Leuk Lymphoma. 2020. PMID: 31992103
Response and Survival Outcomes to Ibrutinib Monotherapy for Patients With Waldenström Macroglobulinemia on and off Clinical Trials.
Castillo JJ, Gustine JN, Meid K, Flynn CA, Demos MG, Guerrera ML, Jimenez C, Kofides A, Liu X, Munshi M, Tsakmaklis N, Patterson CJ, Xu L, Yang G, Hunter ZR, Treon SP. Castillo JJ, et al. Among authors: flynn ca. Hemasphere. 2020 May 21;4(3):e363. doi: 10.1097/HS9.0000000000000363. eCollection 2020 Jun. Hemasphere. 2020. PMID: 32647793 Free PMC article.
Multicenter phase 2 study of daratumumab monotherapy in patients with previously treated Waldenström macroglobulinemia.
Castillo JJ, Libby EN, Ansell SM, Palomba ML, Meid K, Flynn CA, Leventoff C, Hergott CB, Sewastianik T, Morgan EA, Carrasco R, Fromm JR, Yang G, Hunter Z, Treon SP. Castillo JJ, et al. Among authors: flynn ca. Blood Adv. 2020 Oct 27;4(20):5089-5092. doi: 10.1182/bloodadvances.2020003087. Blood Adv. 2020. PMID: 33085756 Free PMC article. Clinical Trial.
Partial response or better at six months is prognostic of superior progression-free survival in Waldenström macroglobulinaemia patients treated with ibrutinib.
Castillo JJ, Abeykoon JP, Gustine JN, Zanwar S, Mein K, Flynn CA, Demos MG, Guerrera ML, Kofides A, Liu X, Munshi M, Tsakmaklis N, King R, Yang G, Hunter ZR, Advani RH, Palomba ML, Ansell SM, Gertz MA, Kapoor P, Treon SP. Castillo JJ, et al. Br J Haematol. 2021 Feb;192(3):542-550. doi: 10.1111/bjh.17225. Epub 2020 Nov 18. Br J Haematol. 2021. PMID: 33207010 Free PMC article. Clinical Trial.
Cell-free DNA analysis for detection of MYD88L265P and CXCR4S338X mutations in Waldenström macroglobulinemia.
Demos MG, Hunter ZR, Xu L, Tsakmaklis N, Kofides A, Munshi M, Liu X, Guerrera ML, Leventoff CR, White TP, Flynn CA, Meid K, Patterson CJ, Yang G, Branagan AR, Sarosiek S, Castillo JJ, Treon SP, Gustine JN. Demos MG, et al. Am J Hematol. 2021 Jul 1;96(7):E250-E253. doi: 10.1002/ajh.26184. Epub 2021 Apr 22. Am J Hematol. 2021. PMID: 33819355 Free article. No abstract available.
Natural history of Waldenström macroglobulinemia following acquired resistance to ibrutinib monotherapy.
Gustine JN, Sarosiek S, Flynn CA, Meid K, Leventoff C, White T, Guerrera ML, Xu L, Kofides A, Tsakmaklis N, Munshi M, Demos M, Patterson CJ, Liu X, Yang G, Hunter ZR, Branagan AR, Treon SP, Castillo JJ. Gustine JN, et al. Among authors: flynn ca. Haematologica. 2022 May 1;107(5):1163-1171. doi: 10.3324/haematol.2021.279112. Haematologica. 2022. PMID: 34162182 Free PMC article.
731 results